![Lars P. Ramneborn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lars P. Ramneborn
Chief Executive Officer at Xantis Pharma AG
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Manuel Vogel | M | 55 |
Xantis Pharma AG
![]() Xantis Pharma AG Pharmaceuticals: MajorHealth Technology Xantis Pharma AG manufactures and wholesales pharmaceutical products. It focuses on cardiovascular, gastroenterology, central nervous system, men’s health, pain, allergy, arthritis and over the counter products. The company was founded in 2015 and is headquartered in Zug, Switzerland. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Miroslav Janoušek | M | 60 |
Zentiva Group as
![]() Zentiva Group as Pharmaceuticals: MajorHealth Technology Zentiva Group as develops, manufactures and markets pharmaceuticals. Its products include generics for the treatment of cardiovascular, central nervous, and blood diseases, as well as anti-inflammatory drugs. The company was founded in 1933 and is headquartered in Prague, Czech Republic. | 10 years |
Carl Martin Svalstedt | M | 61 |
Karlstad University
| 4 years |
Hanspeter Spek | M | 72 |
Zentiva Group as
![]() Zentiva Group as Pharmaceuticals: MajorHealth Technology Zentiva Group as develops, manufactures and markets pharmaceuticals. Its products include generics for the treatment of cardiovascular, central nervous, and blood diseases, as well as anti-inflammatory drugs. The company was founded in 1933 and is headquartered in Prague, Czech Republic. | - |
Olof Persson | M | 60 |
Karlstad University
| 4 years |
Ferit Bülent Eczacibasi | M | - |
Zentiva Group as
![]() Zentiva Group as Pharmaceuticals: MajorHealth Technology Zentiva Group as develops, manufactures and markets pharmaceuticals. Its products include generics for the treatment of cardiovascular, central nervous, and blood diseases, as well as anti-inflammatory drugs. The company was founded in 1933 and is headquartered in Prague, Czech Republic. | 1 years |
Sven Krook | M | 58 |
Karlstad University
| 3 years |
Urs Kamber | M | - |
Zentiva Group as
![]() Zentiva Group as Pharmaceuticals: MajorHealth Technology Zentiva Group as develops, manufactures and markets pharmaceuticals. Its products include generics for the treatment of cardiovascular, central nervous, and blood diseases, as well as anti-inflammatory drugs. The company was founded in 1933 and is headquartered in Prague, Czech Republic. | 4 years |
John Rafferty | M | - |
Zentiva Group as
![]() Zentiva Group as Pharmaceuticals: MajorHealth Technology Zentiva Group as develops, manufactures and markets pharmaceuticals. Its products include generics for the treatment of cardiovascular, central nervous, and blood diseases, as well as anti-inflammatory drugs. The company was founded in 1933 and is headquartered in Prague, Czech Republic. | - |
Petr Pokorny | M | 61 |
Zentiva Group as
![]() Zentiva Group as Pharmaceuticals: MajorHealth Technology Zentiva Group as develops, manufactures and markets pharmaceuticals. Its products include generics for the treatment of cardiovascular, central nervous, and blood diseases, as well as anti-inflammatory drugs. The company was founded in 1933 and is headquartered in Prague, Czech Republic. | - |
Marcel Dostál | M | 54 |
Zentiva Group as
![]() Zentiva Group as Pharmaceuticals: MajorHealth Technology Zentiva Group as develops, manufactures and markets pharmaceuticals. Its products include generics for the treatment of cardiovascular, central nervous, and blood diseases, as well as anti-inflammatory drugs. The company was founded in 1933 and is headquartered in Prague, Czech Republic. | - |
Stefan Kurth Rinaldo | M | 61 |
Karlstad University
| 4 years |
Ruzha Draganova | F | - |
Zentiva Group as
![]() Zentiva Group as Pharmaceuticals: MajorHealth Technology Zentiva Group as develops, manufactures and markets pharmaceuticals. Its products include generics for the treatment of cardiovascular, central nervous, and blood diseases, as well as anti-inflammatory drugs. The company was founded in 1933 and is headquartered in Prague, Czech Republic. | 2 years |
Samuel Rundle | M | - |
Karlstad University
| 3 years |
Karin Sardal | F | - |
Karlstad University
| 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
Czech Republic | 8 | 53.33% |
Sweden | 6 | 40.00% |
Switzerland | 1 | 6.67% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Lars P. Ramneborn
- Personal Network